BioSpace News Archive

Recommends Removal of CEO Mark Baker, Citing ‘Past Questionable Actions’ and ‘Poor Performance’ and Advises ‘DO NOT VOTE’ on the WHITE card

VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, announced today that Eric W. Roberts and Allan L. Shaw have resigned from its Board of Directors and all of its committees in order to increase their focus on other personal business interests.

BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that the Phase 3 clinical trial independent Data Safety Monitoring Board (DSMB) has completed the second, pre-specified interim analysis, of safety outcomes for the first 106 patients who received repeat dosing of NurOwn® in the Phase 3 trial for ALS patients (NCT03280056).

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that clients utilizing Inovalon’s quality improvement solution suite outperformed the entire Medicare Advantage market for the sixth year in a row, realizing an average positive increase in their Centers for Medicare & Medicaid Services (CMS) 2020 Five-Star Quality Ratings of nearly 300% greater than that of health plans not using Inovalon’s analytics.

Biogal Galed Labs, a global leader of veterinary diagnostic solutions, has announced the commercialization of the new RoboComb, an automated development robot for Biogal’s VacciCheck and ImmunoComb kits.

Daré Bioscience, Inc., a leader in women’s health innovation, and Strategic Science & Technologies, LLC, a Cambridge, MA based novel topical drug delivery company, announced a poster presentation at the Sexual Medicine Society of North America 20th Annual Fall Scientific Meeting, which took place in Nashville, Tennessee, October 24-27, 2019.

Mapi Pharma Ltd. announced today that the first patient has been enrolled in its Phase III study with GA Depot for relapsing forms of multiple sclerosis (RMS).

MediciNova, Inc. announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a pending patent application which covers MN-166 for the treatment of amyotrophic lateral sclerosis

Advanced Sterilization Products announced its new brand strategy with a refreshed mission, new logo, and a redesigned website.

TRULANCE® (plecanatide) Poster Presentation Recognized with Presidential Poster Award Distinction